MR编号 | DK/H/2158/001 |
---|
药品名称 | Cefotaxim "MIP" |
---|
活性成分 | - Cefotaxime sodium salt 1.0 g
|
---|
剂型 | Powder for solution for infusion/injection |
---|
上市许可持有人 | MIP Pharma GmbH
Kirkeler Strasse 41
Niederwuerzbach
66440- Blieskastel
Saarland
Germany |
---|
参考成员国 - 产品名称 | Denmark (DK) Cefotaxim "MIP" |
---|
互认成员国 - 产品名称 | - Germany (DE)
Cefotaxim IPP 1 g Pulver zur Herstellung einer Injektions- oder Infusionslösung - United Kingdom (Northern Ireland) (XI)
- Sweden (SE)
47757 - Norway (NO)
Cefotaxim IPP - Finland (FI)
- Latvia (LV)
- Lithuania (LT)
Cefotaxime MIP 1 g milteliai injekciniam arba infuziniam tirpalui - Estonia (EE)
CEFOTAXIME MIP 1G - Hungary (HU)
CEFOTAXIM MIP 1 g por oldatos injekcióhoz vagy infúzióhoz - Bulgaria (BG)
Cefotaxim IPP - Romania (RO)
Cefotaxim MIP 1 g pulbere pentru soluţie injectabilă/perfuzabilă
|
---|
许可日期 | 2013/06/21 |
---|
最近更新日期 | 2025/02/06 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|